| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.3780 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.4649 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5024 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.5967 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.6363 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.6914 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7219 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.7389 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8427 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.8726 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9123 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9314 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9328 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9566 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 0.9904 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0096 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0283 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0349 | relative value | Control |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.0815 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1167 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1174 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.1241 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2094 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2239 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2511 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.2930 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.3393 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.3532 | relative value | MCT-Vehicle |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.3949 | relative value | MCT-SC144 |
| Reversed phase POSITIVE ION MODE | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) | 1.4141 | relative value | MCT-Vehicle |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|